butoxamine has been researched along with Bone Loss, Osteoclastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, S; Hayashi, K; Ishizuka, K; Kondo, H; Miyazawa, K; Muramatsu, R; Sato, T; Sekiya, T; Takeguchi, A; Togari, A; Uchibori, S | 1 |
1 other study(ies) available for butoxamine and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Suppression of tooth movement-induced sclerostin expression using β-adrenergic receptor blockers.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Bone Morphogenetic Proteins; Bone Remodeling; Bone Resorption; Butoxamine; Genetic Markers; Osteoclasts; Osteocytes; Propranolol; RANK Ligand; Rats; Rats, Inbred SHR; Tooth Movement Techniques | 2020 |